Expression data derived from adenocarcinoma or neuroendocrine prostate cancer of TRAMP and SPARC deficient TRAMP mice.

In this dataset we show transcriptional profiles derived from adenocarcinoma or incipient neuroendocrine prostate cancer (NEPC) derived from TRAMP or SPARC-deficient TRAMP mice respectively. Genetic ablation of SPARC rendered prostate cancer cells to be prone to NEPC differentiation. Total RNA was obtained from prostate tumors from 18 and 30-week-old with SPARC-deleted TRAMP mice with adenocarcinoma and NEPC (n=7 for each time point and tumor type). Then, we performed transcription array with Clariom S assay.